ACTIVIN RECEPTOR LIGAND FOR THR TREATMENT OF BETA-THALASSEMIA: a SERENDIPITOUS DISCOVERY
b-thalassemia is a hereditary disorder caused by defective production of b-globin chains of hemoglobin (Hb) that leads to an increased a/b globins ratio with subsequent free a-globins. Alpha globin excess causes oxidative stress, RBCs membrane damage, premature death of late-stage erythroid precurso...
        Saved in:
      
    
          | Main Authors: | Irene Motta, Valentina Brancaleoni, Isabella Nava, Paola Delbini, Lorena Duca | 
|---|---|
| Format: | Article | 
| Language: | English | 
| Published: | PAGEPress Publications
    
        2020-10-01 | 
| Series: | Mediterranean Journal of Hematology and Infectious Diseases | 
| Online Access: | http://www.mjhid.org/index.php/mjhid/article/view/4358 | 
| Tags: | Add Tag 
      No Tags, Be the first to tag this record!
   | 
Similar Items
- 
                
                    Pseudo-sérendipité et contre-sérendipité dans les conceptions temporelles révolutionnaires        
                          
 by: Olivier Lamoureux-Lafleur
 Published: (2017-03-01)
- 
                
                    Elritercept, a modified activin receptor IIA ligand trap, increased erythropoiesis and thrombopoiesis in a phase 1 trial        
                          
 by: Jennifer Lachey, et al.
 Published: (2025-01-01)
- 
                
                    Thyroid hormone receptor beta (THRβ1) is the major regulator of T3 action in human iPSC-derived hepatocytes        
                          
 by: Lorraine Soares De Oliveira, et al.
 Published: (2024-12-01)
- 
                
                    Le modèle de la sérendipité        
                          
 by: Robert K. Merton
 Published: (2017-03-01)
- 
                
                    Activins and Inhibins in Cardiovascular Pathophysiology        
                          
 by: Wenyi Tang, et al.
 Published: (2024-11-01)
 
       